Clinical Trial Update: Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of acetyllevocarnitine hydrochloride tablets in Chinese patients with diabetic peripheral neuropathy and paresthesias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Acetyllevocarnitine hydrochloride tablets (acetyllevocarnitine hydrochloride)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Diabetic Peripheral Neuropathy (DPN), Paresthesia | Phase 3 | Status: COMPLETED